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Mitochondrial fitness is central to heart health. In many cell types, mitochondria are dynamic, interconnected
filamentous networks. By comparison, mitochondria of healthy postmitotic adult cardiomyocytes are short-
ened, round, hypodynamic organelles. Mitochondrial networks are absent in cardiomyocytes; fission, fusion,
and organelle mobility are not normally observed. Nevertheless, mitochondrial fission factor Drp1 and fusion
factorsMfn1,Mfn2, andOpa1 are abundant and indispensable in adult hearts. Here, we review recent insights
into roles for mitochondrial dynamics factors not strictly related to morphometric remodeling, advancing the
argument that fission and fusion of cardiomyocyte mitochondria support surveillance, sequestration, and
mitophagic removal of damaged organelles.Overview
The past decades have witnessed an explosion in our under-
standing of the lives of mitochondria. What likely began as a
commensal relationship between endosymbiotic protobacteria
and host unicellular organisms has, over eons, evolved into the
most breathtakingly successful and expansive example of
synergistic mutualism in the animal kingdom. As mitochondria
and their hosts (i.e., us) coevolved, we have become almost
completely codependent. Thus, mitochondria exported 99%
of their genome to cell nuclei and consequently rely upon host
cells to transcribe DNA and translate mRNA encoding all but
13 (of 1,000) mitochondrial proteins; the cells do the work of
making mitochondrial proteins, and the mitochondria import
them through a complex and highly regulated sorting machinery
(Schmidt et al., 2010). In exchange, host cells have come to rely
on highly efficient mitochondrial oxidative phosphorylation,
rather than glycolysis, as the major source of ATP to fuel normal
cell functions. While we continue to unravel the mechanisms
underlying mitochondrial metabolism, research into the newer
areas of mitochondrial dynamics and quality control has
revealed unanticipated behaviors that mediate interactions
between individual mitochondria within the greater cellular col-
lective, and that determine how these organelles communicate
and collaborate with their host cells to maintain overall fitness
of the mitochondrial pool. Far from being static transmutators
of hydrocarbons and oxygen to ATP, mitochondria are dynamic
entities with an ability to homeostatically orchestrate (or patho-
logically disrupt) cell specification/differentiation during embry-
onic development, programmed cell elimination during organ/
organism senescence, and virtually every other cellular function
in the intervening period.
It has become axiomatic that mitochondria constantly un-
dergo fission, fusion, and migration within cells (Liesa and
Shirihai, 2013), collectively termed ‘‘mitochondrial dynamism.’’
The supporting evidence for this conclusion is overwhelming;
one needs only to look at movies of living cultured fibroblasts
after their mitochondria have been stained with, or are geneti-cally expressing, one or more fluorescent markers (Archer,
2013). The filamentous mitochondrial networks are constantly
remodeling, with sections of the network periodically breaking
away and then re-establishing new interconnections elsewhere.
Mitochondrial morphometry seems especially plastic during cell
mitosis (Taguchi et al., 2007), perhaps in part to accommodate
massive changes in the cell’s internal architecture, size, and
shape, and to facilitate distribution of mitochondria to both
daughter cells. Dissolution of the mitochondrial network is also
frequently observed during programmed apoptotic cell death
(Frank et al., 2001). While many of the molecular mediators
have been identified, the underlying mechanisms for mitochon-
drial remodeling are not yet fully understood (Youle and van
der Bliek, 2012).
The general characterization of mitochondria as ‘‘highly dy-
namic’’ does not apply to adult cardiac myocytes. Compared
to prototypical cultured fibroblasts, normal cardiomyocyte mito-
chondria exhibit a smaller, rounder, so-called ‘‘fragmented’’
morphometry and do not routinely travel within the cell. For
this reason, the widely accepted notion that mitochondrial frag-
mentation is detrimental (and mitochondrial fusion is beneficial)
to mitochondrial and cellular functioning likely does not apply
to adult cardiomyocytes, at least under normal conditions.
Here, we review recent findings supporting the view that mito-
chondrial dynamism plays different roles according to biological
context. We examine accumulating evidence that adult cardio-
myocyte mitochondria represent a ‘‘special case’’ in which les-
sons learned from studying cultured noncardiomyocytes should
be applied with caution as our understanding of the processes
that govern, and the cellular effects that are evoked by, mito-
chondrial fission and fusion continues to evolve.
Wherefore Art Thou, Mitochondria?
Mitochondria serve the same function in cells as does the kitchen
of a busy restaurant: both structures provide a discrete space in
which imported raw materials undergo potentially dangerous
manipulations to produce ‘‘food’’ for consumption. In bothCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 195
Figure 1. Compartmentalization of Mitochondrial Processes and
Signaling Interactions with Host Cell
OMM is outer mitochondrial membrane; IMM is inner mitochondrial mem-
brane; IMS is intermembrane space between the outer and inner membranes;
the matrix is the space within the inner membrane. (Lower) Electron transport
chain resides on the IMM, and ATP is synthesized by F1/Fo ATPase (also
known as complex V). Excessive ROS can damage DNA and proteins within
and outside the mitochondria, and activate regulatory pathways. (Upper)
Endoplasmic/sarcoplasmic reticulum (ER/SR) membrane tethers to the OMM,
facilitating interorganelle calcium signaling. (Right) Calcium can trigger mito-
chondrial permeability transition pore (MPTP) opening, leading to electron
efflux and water influx that causes mitochondrial swelling and even cell death.
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efficiency but also helps to sequester unpleasant or deleterious
byproducts of the primary process. Mitochondrial architecture
(and that of related chloroplasts) is therefore defined by its
principal purpose, oxidative phosphorylation. Enzymes of the
electron transport system reside on a highly convoluted inner
mitochondrial membrane (IMM) (or in chloroplasts, on the thyla-
koids) encompassing a protein-rich mitochondrial matrix that
also contains mitochondrial DNA and ribosomes (Figure 1). The
matrix and IMMare surrounded by the outer mitochondrial mem-
brane (OMM), creating a small intermembrane space; the proton
gradient that drives IMM ATP synthase (a.k.a. F1/Fo ATPase) ex-
ists between this mitochondrial intermembrane space and the
matrix. The dual-membrane mitochondrial structure has some
intriguing implications. First, the matrix, IMM, and intermem-
brane space are physically sequestered by the OMM from the
rest of the host cell; access is limited by passive diffusion or
active translocation across the OMM. Second, as mitochondria
replicate and communicate via fission and fusion, these pro-
cesses have to navigate the complicated internal organelle
architecture (the molecular mechanisms by which this is accom-
plished are described below). Finally, mitochondrial sequestra-
tion inside the OMM insulates the rest of the cell from potent
biochemical reactions taking place within the organelle. The
insular physical relationship between mitochondrion and cell is
essential both to promote mitochondrial respiratory function
and for cytoprotection in the face of mitochondria-generated
reactive oxygen species (ROS) (Figure 1). But this degree of196 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.compartmentalization introduces problems for organelle-cell
and organelle-organelle communications. The biological solu-
tion was for the OMM to not simply passively contain mitochon-
drial oxidation-reduction reactions, but for it to actively engage
both the mitochondrion and the cell as the physical and func-
tional interface for information exchange (i.e., signaling). Thus,
two additional functions of the OMM are to regulate mitochon-
drial morphometry and network morphology in accordance
with changing minute-by-minute needs of the host cell, and to
mediate cell-based mitochondrial removal mechanisms for
organelles that are damaged beyond repair. Mitochondrial dyna-
mism is central to both of these functions.
What Does Mitochondrial Dynamism Accomplish?
Mitochondria are gregarious. In cultured fibroblasts they are
literally conjoined, forming a continuous (albeit constantly
changing) filamentous network through which signaling events
can be transmitted as propagating waves (Szabadkai et al.,
2004). The changing network morphology is the net conse-
quence of multiple simultaneous organelle fusion and fission
events orchestrated by local factors such as mitochondrial
polarization status, proximity of endoplasmic reticulum (ER),
and activity of the Parkin mitophagy signaling pathway (Fried-
man et al., 2011; Liu et al., 2009; Twig et al., 2008; Yang and
Yang, 2013). Even in neurons, in which long axonal structures
(a meter or more of axon between cell body and distal synapse)
are not conducive to maintenance of interconnected mitochon-
drial networks, individual mitochondria migrate bidirectionally
along the axons, intermittently fusing with and transferring con-
tents into other mitochondria (Cagalinec et al., 2013). These
types of observations engendered the notion that mitochondria
are ‘‘highly dynamic, interconnected organelles’’ (DuBoff et al.,
2013).
In most cells mitochondrial networks are dynamic. It seems
obvious, therefore, that a major determinant of mitochondrial
morphology is the relative frequency of mitochondrial fusion
and fission. Mitochondrial shape is typically reported as the
aspect ratio, i.e., length/width (normal value is 6 in fibroblasts)
(Song et al., 2015). When fusion and fission are balanced, mito-
chondrial aspect ratio will be stable. However, when the balance
shifts in favor of more fusion (and/or less fission), mitochondrial
elongation and network connectivity will increase. And when
an imbalance produces less fusion (and/or more fission), this
will provoke accumulation of smaller, shorter ‘‘fragmented’’ or-
ganelles. Unless it is established that the underlying mechanism
for organelle dysmorphology is increased mitochondrial fission,
we prefer the use of ‘‘shorter’’ to describe smaller, rounder mito-
chondria; this neutral term does not imply that active mitochon-
drial ‘‘fragmentation’’ (rather than passive loss of fusion) induced
the structural change.
Dissolution of mitochondrial networks and mitochondrial
shortening (in this case, actual fragmentation) are frequently
observed at the beginning and end of cellular life, i.e., during
mitotic cell division and apoptotic cell death (Frank et al., 2001;
Taguchi et al., 2007). However, genetically ablating mito-
chondrial fusion factors (Chen et al., 2005; Song et al., 2015) or
driving profission factors (Szabadkai et al., 2004) provokes
mitochondrial shortening without killing the cells (although mito-
chondrial fitness is impaired). Indeed, mitochondrial network
Figure 2. Mitochondrial Dynamics Factors
and Mitochondrial Fission and Fusion
(Left) Drp1 is dynamin-related protein 1; Opa1 is
optic atrophy 1; Mfn1 and Mfn2 are mitofusins.
(Upper right) Mitochondrial fission before and
during apoptosis. (Lower right) Mitochondrial
morphology during mitosis. Mitochondria undergo
fission during the mitotic phase, and after cytoki-
nesis, fragmented mitochondria restore the fila-
mentous morphology through mitochondrial fusion
in daughter cells.
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described below, adult cardiomyocytes that lack interconnected
mitochondrial networks (their mitochondria appear constitutively
‘‘fragmented’’) have both the greatest mitochondrial density and
the highest respiratory capacity of any mammalian cell. Thus, at
least in cardiomyocytes, mitochondrial networking is dispens-
able to normal cell functioning. Nevertheless, mitochondrial
fusion clearly plays important and incompletely understood roles
in organism development, as revealed by embryonic lethality in
mice lacking either Mfn1 or Mfn2 in the germline (Chen et al.,
2003) or both Mfn1 and Mfn2 in developing embryonic cardiac
myocytes (Kasahara et al., 2013).
Although not universally accepted, conventional wisdom
holds that mitochondrial fusion/fission and the resulting inter-
mixing of matrix components between two mitochondria are
important for repairing mitochondrial damage by functional
complementation (Chen et al., 2010a; Nakada et al., 2001; Youle
and van der Bliek, 2012). For example, mitochondrial ‘‘kiss and
run’’ describes transient fusion, and then immediate fission, of
two mitochondria that exchange biological components without
changing organelle morphology (Liu et al., 2009). Although this
may be reparative, it also may simply be a mechanism for inter-
organelle information exchange. Further support for a reparative
function of mitochondrial fusion is the classic observation that
fusion-defective murine embryonic fibroblasts (MEFs) exhibit
widespread heterogeneity in mitochondrial membrane potential
(Chen et al., 2005; Olichon et al., 2003). Partial mitochondrial
depolarization in this context was widely interpreted as the
consequence of loss of fusion-mediated complementation, but
recent identification of noncanonical functions for mitochondrial
fusion proteins in mitophagy raises the possibility that mitochon-
drial degeneration in fusion-impaired cells reflects interrupted
organelle quality surveillance and culling (Chen and Dorn,
2013; Lee et al., 2012; Pham et al., 2012; Sebastia´n et al., 2012).
Mitofusins and Drp1—The OMM Dynamic Duo
Before examining the atypical functions of mitochondrial dy-
namics factors in cardiomyocytes, it is worth reviewing the mo-
lecular mechanism of their conventional roles in cells having
mitochondrial networks. Consider that a mitochondrial network
is a bit like a balloon animal. It is malleable and the overall struc-
ture can be readily altered by fairly simplemanipulations within orCell Metabolism 21between individual organelles/balloons.
The process of mitochondrial constriction
that precedes actual organelle fission
is similar for mitochondria and party
balloons: the structure is pinched andconstricted to form a separate entity. In mitochondria this is
accomplished by the cytosolic dynamin family GTPase, dyna-
min-related protein 1 (Drp1) (Figure 2). Normally, 97% of
Drp1 is cytosolic (Smirnova et al., 2001), but its recruitment to
one or more binding proteins on OMMs (Otera et al., 2010;
Palmer et al., 2011; Tieu and Nunnari, 2000; Zhao et al., 2011),
self-assembly into spirals, and GTP-mediated constriction
severs the organelle (Friedman et al., 2011; Ingerman et al.,
2005). Mitochondrial constriction sites are often marked by ER,
and the ER-mitochondria contact is prior to and independent
of Drp1 recruitment (Friedman et al., 2011). As one would
predict, mitochondria in fibroblasts lacking Drp1 exhibit elon-
gated/filamentous morphologies and are resistant (but not
immune) to mitochondrial fragmentation normally induced by
mitochondrial uncoupling agents or during mitosis (Figure 2).
Fragmentation of Drp1-deficient mitochondria during cytoki-
nesis reveals, however, that mitochondrial fission can also be
induced by factors other than Drp1 (Ishihara et al., 2009),
perhaps including Parkin that evokes mitochondrial fragmenta-
tion during mitophagy (Yang and Yang, 2013).
Mitochondrial fragmentation is almost always observed before
or during apoptosis (Figure 2), and Drp1 has therefore been
mechanistically implicated in programmed cell death. Drp1 stim-
ulates Bax oligomerization and cytochrome c release by promot-
ing tethering and hemifusion of membranes duringmitochondrial
fission (Frank et al., 2001). In some studies, genetic or chemical
inhibition of Drp1 decreased cytochrome c release and blocked
cell death, suggesting a contributory effect of mitochondrial
fission in apoptosis (Cassidy-Stone et al., 2008; Frank et al.,
2001). In others, however, inhibition of Drp1-mediated fission
did not prevent release of proapoptotic Smac/DIABLO or reduce
cell death (Estaquier and Arnoult, 2007; Parone et al., 2006), and
in at least some instances, enhanced Drp1-mediated fission can
protect against apoptosis (Szabadkai et al., 2004). Thus, it is
probably most correct to conclude that Drp1-mediated mito-
chondrial fission can be a contributory factor in cell apoptosis,
and likely helps in the cell-wide disassembly that characterizes
this form of ‘‘clean’’ cell suicide, but is not essential to actual
apoptotic cell demise.
When conceptualizing mitochondrial fusion, the balloon anal-
ogy fails because balloons have only one wall, and fusion of
the two mitochondrial membranes (OMM and IMM) requires, February 3, 2015 ª2015 Elsevier Inc. 197
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tionarily conserved OMM fusion proteins (which are also dyna-
min family GTPases) are the mitofusins (Mfn1 and Mfn2) (Chen
et al., 2003; Santel and Fuller, 2001) (Figure 2). Mitofusins are
constitutively localized at the OMM, where they have several
physiologically distinct functions. Their titular function is fusion
of the OMM, which requires GTPase activity and is irreversible.
Mfn1 and Mfn2 are largely redundant for this function, and can
interact either homotypically (Mfn1-Mfn1, Mfn2-Mfn2) or hetero-
typically (Mfn1-Mfn2), although differences in their GTPase ac-
tivity (Ishihara et al., 2004) likely underlie the modest differences
in mitochondrial morphology exhibited by MEFs lacking one or
the other Mfn (Chen et al., 2005). By comparison, MEFs lacking
both Mfn1 and Mfn2 have markedly shortened and partially de-
polarized mitochondria (Chen et al., 2003; Koshiba et al., 2004;
Olichon et al., 2003).
A mechanistically distinct but functionally related effect of
mitofusins is organelle tethering. This is distinct from membrane
fusion because it is fully reversible and does not require hydroly-
sis of GTP. Tethering of two mitochondria both precedes and
enables OMM fusion (Koshiba et al., 2004). Mfn2 (but not
Mfn1) can, however, also localize to endoplasmic reticulum
(and sarcoplasmic reticulum in cardiomyocytes), thereby
tethering ER/SR to mitochondria and facilitating interorganelle
calcium signaling (Chen et al., 2012b; de Brito and Scorrano,
2008). The consequences of Mfn2-facilitated calcium crosstalk
are (1) enhanced bioenergetic responsiveness to temporary
increases in metabolic demand and (2) increased calcium-
mediated opening of mitochondrial permeability transition pores
(MPTPs) under conditions of ischemic stress (Dorn et al., 2015).
Finally, after posttranslational modification, Mfn2 can act as a
mitochondrial receptor protein for Parkin translocation during
mitophagic organelle culling (Chen and Dorn, 2013); the impor-
tance of this in hearts is discussed below.
As a matter of completeness, optic atrophy 1 (Opa1) is the
fourth dynamin family GTPase involved in mitochondrial dyna-
mism. Opa1 is localized on, and mediates fusion of, the IMM
(Figure 2). It is also essential to maintaining proper IMM architec-
ture in the form of cristae (Frezza et al., 2006). Depletion of Opa1
induces heterogeneity in mitochondrial morphometry because
IMM fusion is interrupted, but OMM fusion still occurs (Song
et al., 2009).
At first glance, a broad biological imperative for mitochondrial
dynamism seems to be supported by the embryonic lethality
provoked by germline ablation of these core fission/fusion fac-
tors in mice (Chen et al., 2003; Davies et al., 2007; Ishihara
et al., 2009). However, most of the genetic human syndromes
attributed to mutations in these factors show remarkably
restricted effects. For example, loss-of-function mutations of
Mfn2 are linked to Charcot-Marie-Tooth disease (type 2A), which
is an autosomal dominant syndrome characterized by neuropa-
thy of the peripheral axons (Verhoeven et al., 2006). Likewise,
Opa1 mutations are linked to autosomal-dominant optic atro-
phy, a neurodegenerative condition that specifically targets
retinal ganglion cells (Delettre et al., 2000). Thus, multiple loss-
of-function mutations in these two mitochondrial fusion proteins
are clearly deleterious, but the major adverse effects are limited
to distinct cellular subtypes within the neurological system.
These experiments of nature pose some intriguing questions: If198 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.mitochondrial fusion is generally important, why are the conse-
quences of human Mfn2 and Opa1 mutations so limited? And
given that GTPase activity of Mfn1 is more efficient than Mfn2
(Ishihara et al., 2004), why have there not been reports of human
disease linked to damaging mutations of Mfn1 (which are
approximately as abundant as damaging mutations of Mfn2 in
the 6,000 exomes currently reported by the NHLBI Exome
Sequencing Project)? Finally, if Mfn1 and Mfn2 exhibit functional
redundancy as mitochondrial fusion factors, and mitochondrial
fusion is their most critical role, shouldn’t their selective ablation
from different mouse tissues evoke similar phenotypes? They do
not. In each instance with which we are familiar, loss of Mfn2 has
induced dysfunction, but loss of Mfn1 has been well tolerated
(Chen andDorn, 2013; Lee et al., 2012; Pham et al., 2012; Sebas-
tia´n et al., 2012). It is said that when your theory no longer fits the
facts you should develop a new theory. Thus, one possible
explanation is that mitochondrial fusion is not important, which
we do not accept. Another possibility is that mitochondrial reli-
ance on dynamism is dependent upon cell type. Based in part
on the above observations, and informed by studies in the heart,
we postulate that noncanonical functions of mitochondrial fusion
and fission factors contribute to cell and organ dysfunction
evoked by genetic mutation or ablation.
Mitochondrial Dynamism in the Heart—NOT
The broad generalizations about mitochondrial dynamism intro-
duced above simply do not apply to mitochondria in cardiac
myocytes of normal adult hearts. Cardiomyocyte mitochondria
are not ‘‘highly dynamic,’’ or ‘‘interconnected,’’ or ‘‘constantly
undergoing fission and fusion.’’ Let’s examine each of these
mischaracterizations individually. While it is almost certain
that mitochondria within adult cardiomyocytes can eventually
migrate to a different position within the cell, such organelle
translocation is not directly observed (Dorn et al., 2011). Over
periods of time when the cardiomyocyte would have been
contracting thousands of times, cardiomyocyte mitochondria
appear static. Nor are they connected into networks. It is
apparent from ultrastructural examination of myocardium that
individual cardiomyocyte mitochondria exist as relatively short
organelles (aspect ratio 1.5) collectively grouped together be-
tween myofibrillar elements in lanes that extend parallel to the
long axis of the cell (see Figure 4). Even in the perinuclear region
of cardiomyocytes, where mitochondria tend to be clustered in
large numbers, filamentous organelles and interconnected net-
works are not observed. We have speculated that intrinsically
fragmented mitochondria confer a biomechanical advantage
to striated muscle because interconnected organelles would
constitute an internal resistance element detrimental to myocyte
contraction (Dorn and Kitsis, 2015). Finally, cardiomyocyte mito-
chondria do not undergo fusion and fission at a rate that can be
directly measured. Based on temporally defined cardiomyocyte-
specific ablation of Mfn1 and Mfn2 in combination, or Drp1
alone, the mitochondrial fusion-fission cycle takes approxi-
mately 2 weeks in adult mice (Chen et al., 2011; Song et al.,
2015). Nevertheless, mitochondrial fusion and fission proteins
are expressed at high abundance in adult hearts and can be
regulated in heart disease (Chen et al., 2009, 2011; Fang et al.,
2007; Givvimani et al., 2014; Li et al., 2014; Martin et al., 2014;
Shen et al., 2007), and cardiac-specific ablation of either Mfn1
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alone), evokes cardiac dysfunction, albeit with strikingly different
characteristics (Chen and Dorn, 2013; Chen et al., 2011; Papani-
colaou et al., 2011, 2012b; Song et al., 2015). As discussed
below, these mouse gene manipulations and similar studies in
Drosophila fruit flies have helped to deconvolute themultifaceted
functioning of mitochondrial dynamics factors in hearts.
As noted, mitochondrial fusion in cardiomyocytes occurs
infrequently (Chen et al., 2011), and therefore has not been
directly quantified in cardiomyocytes. Because there are
currently no useful pharmacological fusion inhibitors, its occur-
rence and importance have been inferred from the phenotypes
provoked by cardiomyocyte-specific genetic ablation or sup-
pression of OMM fusion proteins. In Drosophila, cardiomyo-
cyte-specific expression of an RNAi specific to fly mitofusin
(there is only one, called Marf) produced unusually small mito-
chondria in hypocontractile heart tubes; both the organ and
organelle phenotypes were rescued by cardiomyocyte-specific
expression of human Mfn1 or Mfn2 (Dorn et al., 2011). The func-
tionally analogous genetic manipulation in adult mouse hearts,
i.e., combined cardiomyocyte-specific ablation of Mfn1 and
Mfn2, likewise produced abnormally small mitochondria and a
cardiomyopathy (Chen et al., 2011; Papanicolaou et al.,
2012a). Surprisingly, the initial description of mitofusin-deficient
hearts did not uncover a functional defect in the cardiac mito-
chondria (Chen et al., 2011), but subsequent work revealed
that the unusually small mitochondria that accumulate after sup-
pression of mitochondrial fusion escaped isolation using stan-
dard protocols. Using appropriately modified protocols, the
‘‘fragmented’’ mitochondria in Mfn1/Mfn2 double-deficient
hearts were found to have impaired respiration and increased
ROS production (Song et al., 2015). This same report identified
the underlying mechanism for the eccentric cardiomyopathy in
mitochondrial fusion-defective Mfn1/Mfn2 deficient hearts as
impaired mitophagy without cardiomyocyte loss (Song et al.,
2015). This finding is consistent with an important role for Mfn2
in the PINK1-Parkin mitophagy signaling pathway (Chen and
Dorn, 2013), which is described in greater detail below.
Although less thoroughly characterized, interrupting fusion of
IMM by suppressing Opa1 likewise evokes mitochondrial dys-
morphology and cardiomyopathy in Drosophila (Dorn et al.,
2011) and mice (Chen et al., 2012a; Piquereau et al., 2012).
Conversely, Opa1 overexpression in cultured H9C2 cells pro-
duces mitochondrial elongation (which occurred without the
anticipated reduction in apoptosis under conditions of simulated
ischemia) (Chen et al., 2009). Together, these early results of
Opa1 manipulation in cardiomyocytes suggest that (like Mfn1
and Mfn2) Opa1 is indispensable to normal cardiac functioning,
but (like Mfn2) its most important role may not simply be to pro-
mote mitochondrial fusion. Indeed, the most important functions
of Opa1 may derive from its orchestration of mitochondrial
cristae architecture (Cipolat et al., 2006; Cogliati et al., 2013;
Frezza et al., 2006).
It is standard practice to examine biological questions from
opposing perspectives, in anticipation of obtaining reciprocal
results. Accordingly, in addition to modulating fusion, when dis-
secting the consequences of mitochondrial dynamism in the
heart one should determine what happens when fission is inter-
rupted. Pharmacological inhibition can have less molecularspecificity and less precise cellular targeting than genetic inter-
ruption, but investigations using small molecular inhibitors of
Drp1-mediated mitochondrial fission have provided useful infor-
mation. As introduced above, mitochondrial fragmentation is
frequently observed during cell apoptosis. It seemed reason-
able, therefore, to see if inhibition of mitochondrial fragmentation
with the Drp1 inhibitor Mdivi-1 could prevent apoptosis (Cas-
sidy-Stone et al., 2008). The first attempt to use this approach
in cardiomyocytes showed that Mdivi-1 pretreatment of cultured
HL-1 cells improved cell survival and delayed MPTP opening
after simulated ischemia-reperfusion; mice pretreated with
Mdivi-1 developed smaller myocardial infarcts after coronary oc-
clusion-reperfusion (Ong et al., 2010). Mdivi-1 also improved left
ventricular function and decreased myocardial fibrosis in pres-
sure overload-induced heart failure (Givvimani et al., 2012).
Mochly-Rosen’s group has reported similar findings using a
completely different pharmacological Drp1 inhibitor, a synthetic
7 amino acid peptide that selectively disrupts the interaction be-
tween Drp1 and its mitochondrial receptor Fis1 (Qi et al., 2013).
This peptide, designated P110, improved bioenergetics and
functional recovery in primary cardiomyocytes, in ex vivo
perfused hearts, and in vivo ischemia-reperfused hearts (Disat-
nik et al., 2013). It has also slowed neurodegeneration in a trans-
genic mouse model of Huntington’s disease (Guo et al., 2013).
These data strongly suggest that preventing mitochondrial
fission through Drp1 inhibition can be beneficial in ischemically
injured hearts and other disorders in which excessive mitochon-
drial fission has a pathophysiological role.
As noted, pharmacological inhibition and genetic ablation are
not the same and do not provide the same information. There are
limited data on the consequences of genetic loss of Drp1 func-
tion in vertebrate hearts. The potential for Drp1 to play a role
was revealed in an N-ethyl-N-nitrosourea mutagenesis screen,
wherein the ‘‘Python’’ mouse having a Drp1C452F mutation devel-
oped dilated cardiomyopathy associated with reduced levels of
respiratory complexes and ATP depletion (Ashrafian et al., 2010).
The recent availability of Drp1 floxed allele mice (Ishihara et al.,
2009; Udagawa et al., 2014; Wakabayashi et al., 2009) has
permitted organ-specific Drp1 deletion, including in the heart.
Three groups independently combined Drp1 floxed allele mice
with cardiomyocyte-specific Cre deletors to produce cardiac-
specific Drp1 knockout mice (Ikeda et al., 2015; Kageyama
et al., 2014; Song et al., 2015). A detailed comparison of the
data and conclusions of the three papers has been reported
elsewhere (Dorn, 2015). Briefly, Drp1 deficiency induced mito-
chondrial enlargement in all three reports, as expected from
unopposed organelle fusion. In either the perinatal period or in
fully developed adult hearts, loss of cardiac Drp1 proved lethal.
Likewise, in each instance of Drp1 deletion, abnormalities in
mitochondrial quality and/or quantity were associated with dis-
turbances in mitochondrial autophagy. Thus, all three studies
linked mitochondrial fission to quality control, although the spe-
cific nature of the mitophagic dysfunction remains unclear.
Our group’s Drp1 heart knockout study was unique in that we
directly compared the consequences of conditional cardiac
interruption of mitochondrial fission to interruption of mitochon-
drial fusion. Cardiac-specific Drp1 ablation produced fission-
defective cardiomyocyte mitochondria that were not only
enlarged, but whose abundance also progressively decreased.Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 199
Figure 3. Relationship of Mitochondrial Dynamism to Mitophagy
Mitochondria accumulate damage over time. Impaired (partially depolarized)
mitochondrion divides into one depolarized daughter and one hyperpolarized
daughter through asymmetric fission. The depolarized daughter is eliminated
viaMfn2-Parkin-mediatedmitophagy, and the hyperpolarized daughter rejoins
the functional mitochondrial pool through organelle fusion. Healthy mito-
chondria (hyperpolarized) are colored in green and damaged mitochondria
(depolarized) in yellow.
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autophagy increased, especially in the terminal stages of the
progressive dilated cardiomyopathy. Drp1 ablation provoked
programmed cardiomyocyte necrosis that ultimately caused
myocardial fibrosis and lethal cardiac failure. Studies in Drp1-
deficient MEFs revealed inappropriate mitochondrial clearance
and MPTP-mediated cell death, and inhibition of MPTP opening
by pharmacological or genetic suppression of cyclophilin D
rescued cells and hearts, respectively (Song et al., 2015). By
comparison, conditional combined cardiac-specific Mfn1/Mfn2
ablation produced fusion-defective cardiomyocyte mitochon-
dria whose size decreased, but abundance increased with
time. Mitochondrial respiratory fitness was markedly impaired
in these hearts and the mitochondrial uncoupled protein
response was potently induced, but mitophagywas not induced.
Furthermore, although Mfn1/Mfn2-deficient mitochondria pro-
gressively developed striking structural and functional abnor-
malities, cardiomyocyte viability was not compromised (Song
et al., 2015). Thus, deficiency of both mitochondrial fusion
proteins interrupted cardiomyocyte mitophagy; we previously
showed that cyclophilin D ablation does not rescue this type of
mitophagy-suppressed heart phenotype (Song et al., 2014).
It’s the Mitophagy.
James Carville famously developed three focus points for Bill
Clinton’s 1992 presidential campaign; each of these applies
also tomitochondrial dynamism in the heart. The first is ‘‘Change
versus more of the same.’’ The morphology of cardiomyocyte
mitochondria is just ‘‘more of the same.’’ These cells are
40% full of monotonously similar rounded-rectangular mito-
chondria. There are no mitochondrial networks to remodel, and200 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.fission and fusion occur rarely. Even genetic ablation of both mi-
tofusin proteins or the Drp1 fission protein provokes only a
modest change in cardiomyocyte mitochondria size (2-fold
decrease or increase, respectively), compared to complete
mitochondrial fragmentation or hyperfusion in cultured MEFs
undergoing the same conditional gene manipulations (Song
et al., 2015).
Carville’s second focus point was ‘‘Don’t forget health care.’’
The cumulative data seem to indicate that, rather than shape
change, mitochondrial dynamism in hearts is central tomaintain-
ing mitochondrial fitness, i.e., ‘‘health care.’’ Notwithstanding
that the absolute rates of mitochondrial fission and fusion are
slow in mammalian hearts, creating an imbalance between
these two processes through their genetic interruption disrupts
mitochondrial quality control in opposite directions (Song et al.,
2015).
This leads us to the third and most celebrated of Carville’s
focus points: ‘‘It’s the economy, stupid.’’ For cardiomyocyte
mitochondria this translates to ‘‘It’s the mitophagy .’’ Mitoph-
agy, literally the cell eating its mitochondria using the autophagy
apparatus, is a protective mechanism against cell damage
by oxygen radicals released from senescent or functionally
impaired mitochondria (Youle and van der Bliek, 2012). It may
also be a mechanism for recycling mitochondrial components.
The connection between mitochondrial dynamism and mito-
phagy was elegantly described by Shirihai’s group in studies
of cultured INS1 and COS7 cells. They observed asymmetric
fission of modestly damaged (i.e., partially depolarized) mito-
chondria producing one healthy (hyperpolarized) daughter that
rejoined, by fusion, the functional mitochondrial pool, whereas
the other depolarized daughter mitochondrion was specifically
targeted for mitophagic elimination (Twig et al., 2008) (Figure 3).
The critical involvement of mitochondrial fission in sequestering
damagedmitochondrial components into one daughter targeted
for removal, and of mitochondrial fusion in reintroducing
the healthy daughter to the mitochondrial collective, reflects a
central homeostatic function for mitochondrial dynamism inde-
pendent of morphometric or network remodeling. Whereas
cardiomyocyte mitochondria are severely hypodynamic, main-
tenance of mitochondrial fitness is clearly a physiological imper-
ative in this most energy-demanding and mitochondrial rich
organ (Anan et al., 1995; Doenst et al., 2013; Kolwicz et al.,
2013). An immediate example is the aforementioned lethal phe-
notypes and the seemingly opposite effects on mitophagy in
fission-deficient mouse hearts reported by Ikeda et al. (Ikeda
et al., 2015) and our group (Song et al., 2015): at an early stage,
the absence of asymmetric fission prevents damagedmitochon-
drial components being segregated for mitophaghic elimination.
Conservation of damaged components not only impairs mito-
chondrial function but also interrupts normal mitophagy. When
the damage accumulates over time, absence of asymmetric
fission eventually provokes a generalized widespread mito-
phagic response. Consequently, we next examine additional
evidence for and against an important role for the mitochondrial
dynamism-mitophagy interactome (Dorn and Kitsis, 2015) in
mammalian heart function.
Mitophagy is controlled by signaling through two Parkinson’s
disease factors, the mitochondrial kinase PINK1 and the
cytosolic E3 ubiquitin ligase, Parkin (Youle and van der Bliek,
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control was initially uncovered through their genetic epistasis in
Drosophila (Clark et al., 2006; Park et al., 2006). It was only
recently, however, that Youle and colleagues uncovered how
the PINK1-Parkin system achieves selective mitophagy (Naren-
dra et al., 2010). Both PINK1 and Parkin are nuclear encoded.
PINK1 is imported into mitochondria where it is almost immedi-
ately degraded bymitochondrial proteases (Deas et al., 2011; Jin
et al., 2010). PINK1 proteolysis is impaired in damaged or senes-
cent depolarized mitochondria, resulting in its accumulation in
these damaged organelles. Stabilized PINK1 then recruits cyto-
solic Parkin to those depolarized mitochondria, provoking its
ubiquitination of OMM proteins (Sarraf et al., 2013), and thereby
targeting the damaged organelle for autophagosomal engulf-
ment (Yang and Yang, 2013). In this manner PINK1 and Parkin
constitute the central effectors of mitophagy (Figure 3). Their
importance to heart function, and that of mitophagy in general,
is supported by the observation that mice lacking PINK1 exhibit
abnormalities of cardiac mitochondria associated with patho-
logical cardiac hypertrophy and cardiac dysfunction linked to
myocardial fibrosis and increased cardiomyocyte apoptosis (Bil-
lia et al., 2011). Likewise, mice lacking Parkin develop structur-
ally and functionally abnormal mitochondria and associated
age-dependent cardiac abnormalities resembling premature
senescence (Hoshino et al., 2013; Kubli et al., 2013a, 2013b).
Furthermore, cardiomyocyte-specific Parkin overexpression
protects against age-related mitochondrial dysfunction and car-
diac senescence (Hoshino et al., 2013). However, whereas direct
evidence exists for mitochondrial involvement in the skeletal
myopathy of Parkinson’s disease (Ahlqvist et al., 1975; Blin
et al., 1994; Shoffner et al., 1991), cardiac dysfunction is not
common; the only evidence for cardiac involvement is inferential
and derived from purely statistical associations (Zesiewicz et al.,
2004). Likewise, cardiac phenotypes in Parkin knockoutmice are
modest, and develop only later in life (Hoshino et al., 2013; Kubli
et al., 2013b), but this may be a consequence of compensatory
upregulation of related ubiquitin ligases in the germline Parkin
knockout mouse heart (Bhandari et al., 2014).
In a fascinating example of scientific convergence, emerging
data have revealed essential roles for proapoptotic Bcl-2 family
proteins Nix and Bnip3 in homeostatic mitochondrial signaling
and quality control (reviewed in Dorn and Kitsis, 2015). Thus,
Bnip3 and Nix (also called Bnip3L) are induced and evoke
apoptotic cardiomyocyte death in damaged or stressed mouse
hearts (Chen et al., 2010b; Diwan et al., 2007, 2008; Syed
et al., 2004; Yussman et al., 2002), but their combined ablation
in otherwise normal hearts provokes the accumulation of
abnormal mitochondria and causes an apparent cardiomyopa-
thy of mitophagic dysfunction (Dorn, 2010). The molecular
underpinnings of Nix and Bnip3 involvement in mitochondrial
quality control are diverse: Nix (and likely Bnip3) regulates
calcium signaling between cardiomyocyte mitochondria and
endo/sarcoplasmic reticulum (Chen et al., 2010b; Diwan et al.,
2009). Nix and Bnip3 also promote the physical association of
depolarized mitochondria with autophagosomes (Ding et al.,
2010; Glick et al., 2012; Hanna et al., 2012; Schwarten et al.,
2009). The involvement of Nix, Bnip3, and other Bcl2 proteins
in mitochondrial quality control led us to postulate that pro-
grammed elimination of individual dysfunctional mitochondria(i.e., mitophagy) and programmed elimination of individual
dysfunctional cells (i.e., apoptosis) are more a matter of scale
rather than distinct molecular mechanisms (Dorn and Kitsis,
2015).
Recent work from our group further supported the importance
of mitophagic mitochondrial quality control to mammalian
hearts, and described an unsuspected interaction between
mitochondrial dynamism and mitophagy. During the course of
investigating the mitochondria-SR tethering function of Mfn2 in
mouse hearts (Chen et al., 2012b), we observed that postnatal
cardiac-specific deletion of Mfn2 provoked the gradual accumu-
lation of abnormal cardiomyocyte mitochondria, and hypothe-
sized that absence of Mfn2 induced a defect in mitochondrial
quality control. Consistent with this notion, we demonstrated
that Mfn2 functionally links mitochondrial PINK1 activity to
translocation and activation of cytosolic Parkin, and identified
PINK1-phosphorylated Mfn2 as the first known mitochondrial
Parkin receptor (Chen and Dorn, 2013). More recently, we
demonstrated two different roles for mitochondrial-derived
ROS in thismodel of defective cardiacmitophagy. First, in accor-
dance with conventional wisdom, mitochondrial ROS were
increased in Mfn2-deficient hearts, and their normalization
by transgenic expression of mitochondrial-targeted catalase
(mCAT) delayed and improved the cardiomyopathy (Song
et al., 2014). This uncovered ROS cardiotoxicity that was linked
to retention of abnormal mitochondria after normal mitophagic
culling mechanisms were interrupted, similar to aged Parkin
knockout mouse hearts (Hoshino et al., 2013). However, we
also uncovered evidence that mitochondrial ROS can induce
compensatory secondary mitochondrial autophagy mecha-
nisms: suppressing mitochondrial ROS to levels far below
normal both exacerbated the accumulation of damaged mito-
chondria and accelerated the associated cardiomyopathy in
the same mitophagically impaired hearts (Song et al., 2014).
This demonstrates that increased ROS in damaged or senescent
mitochondria can stimulate mitochondrial culling independent of
the classic PINK1-Mfn2-Parkin pathway. Taken together, these
studies mechanistically link mitochondrial fusion and mitophagy
through Mfn2, and mitotoxicity and quality control through ROS.
Tantalizingly, the dual roles of Mfn2 as an initiator of mitochon-
drial fusion and a critical effector of PINK1-Parkin-mediated
mitophagy position it at the pivot point in the cellular decision
pathway for managing damaged mitochondria via repair versus
removal.
What the Future May Hold ...
As much as it might simplify biomedical research, a man will
never be a mouse (or a fly), and a cardiomyocyte is not a fibro-
blast. If one accepts our premise that the most basic lessons
of mitochondrial dynamism gleaned from studies of cultured
fibroblasts and similar cells can be misleading when applied to
the unique characteristics of adult cardiac myocytes, then it is
obvious that we need better research platforms and experi-
mental systems. This is not news. Researchers have long used
immortalized cells having some characteristics of cardiac myo-
cytes (e.g., H9C2, AT-1, and HL-1 cells) or neonatal rat and
mouse cardiac myocytes to better understand the cell biology
of cardiac hypertrophy and failure; frequently such studies
were used to supplement and complement data from in vivoCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 201
Figure 4. Mitochondrial Morphologies in Different Cell Types
Murine fibroblasts and human induced pluripotent stem cells (hiPSC)-derived cells were costained with anti-TOMM20 (green) and anti-cardiac Troponin T (cTnT,
red), and mounted in DAPI. In the image of hiPSC-derived cells, the cTnT-positive cell (middle) is a spontaneously contracting cardiomyocyte with mostly
fragmented mitochondria, and the cTnT negative cell (lower left) is a fibroblast with filamentous mitochondria. The mouse cardiomyocyte was isolated from an
adult mouse heart expressing a mitochondrial-targeted fluorescent green marker. The transmission electron microscopic image of adult mouse heart was taken
at a magnification of 2,0003.
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This approach has been applied with some success to studies of
mitochondrial dynamism and quality control (Ong et al., 2010;
Siddall et al., 2013). However, the mitochondrial architecture of
these cells more resembles fibroblasts than adult cardiomyo-
cytes. We have performed studies in Drosophila in which cardi-
omyocyte mitochondria have many of the same morphometric
and functional characteristics as in mammals, but mechanistic
investigations are limited by the small size and minimal protein
content of fruit fly heart tubes (Bhandari et al., 2014; Chen
et al., 2012b, 2014; Chen and Dorn, 2013; Dorn et al., 2011).
Recently, we and others have taken advantage of improved
techniques for differentiating cardiomyocytes from human
inducible pluripotent stem cells (hiPSC-CM) (Lian et al., 2013;
Takahashi et al., 2007) to manipulate and examine the effects
of mitochondrial fusion factors in functional cultured human car-
diomyocytes. In theory, hiPSC-CM can be a nearly unlimited
resource for studying the cell biology of cardiac disorders (Priori
et al., 2013). Joseph Wu and colleagues have demonstrated the
utility of this system for studying familial dilated cardiomyopathy
(Sun et al., 2012) and viral myocarditis (Sharma et al., 2014). Wu
and Mochly-Rosen recently used hiPSC-CM to understand
mitochondrial and cellular dysfunction conferred by a human
mutation in aldehyde dehydrogenase (Ebert et al., 2014). In our
hands, like mitochondria of adult cardiac myocytes, mitochon-
dria of hiPSC-CM tend to be short and localized between myofi-
brillar elements (Figure 4). By comparison, mitochondria of those
hiPSC-derived cells that fail to differentiate into cardiomyocytes
retain the filamentous morphometry and network architecture
characteristic of fibroblasts (Figure 4). Since only 60%–80% of
the hiPSC-derived cells actually differentiate into spontaneously
contracting cardiacmyocytes (our unpublished results), this pro-
vides a unique side-by-side system perfect for comparing and
contrasting the effects of different genetic and environmental
manipulations on cardiomyocyte and nonmyocytemitochondria.
Together with new in vivo genetic models, such improved in vitro
systems are likely to propel investigations toward more fully
understanding the functional integration of mitochondrial dyna-
mism,mitochondrial quality control, and other biological aspects202 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.of the ancient commensalism that exists between our mitochon-
dria and us.
ACKNOWLEDGMENTS
This work was supported by NIH HL59888 (G.W.D.) and an American Heart
Association predoctoral fellowship award (M.S.).
REFERENCES
Ahlqvist, G., Landin, S., and Wroblewski, R. (1975). Ultrastructure of skeletal
muscle in patients with Parkinson’s disease and upper motor lesions. Lab.
Invest. 32, 673–679.
Anan, R., Nakagawa, M., Miyata, M., Higuchi, I., Nakao, S., Suehara, M.,
Osame, M., and Tanaka, H. (1995). Cardiac involvement in mitochondrial dis-
eases. A study on 17 patients with documented mitochondrial DNA defects.
Circulation 91, 955–961.
Archer, S.L. (2013). Mitochondrial dynamics—mitochondrial fission and fusion
in human diseases. N. Engl. J. Med. 369, 2236–2251.
Ashrafian, H., Docherty, L., Leo, V., Towlson, C., Neilan, M., Steeples, V., Ly-
gate, C.A., Hough, T., Townsend, S., Williams, D., et al. (2010). A mutation in
the mitochondrial fission gene Dnm1l leads to cardiomyopathy. PLoS Genet.
6, e1001000.
Bhandari, P., Song, M., Chen, Y., Burelle, Y., and Dorn, G.W., 2nd. (2014).
Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts
and its containment by suppressing mitofusin. Circ. Res. 114, 257–265.
Billia, F., Hauck, L., Konecny, F., Rao, V., Shen, J., and Mak, T.W. (2011).
PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart func-
tion. Proc. Natl. Acad. Sci. USA 108, 9572–9577.
Blin, O., Desnuelle, C., Rascol, O., Borg, M., Peyro Saint Paul, H., Azulay, J.P.,
Bille´, F., Figarella, D., Coulom, F., Pellissier, J.F., et al. (1994). Mitochondrial
respiratory failure in skeletal muscle from patients with Parkinson’s disease
and multiple system atrophy. J. Neurol. Sci. 125, 95–101.
Cagalinec, M., Safiulina, D., Liiv, M., Liiv, J., Choubey, V., Wareski, P., Veksler,
V., and Kaasik, A. (2013). Principles of the mitochondrial fusion and fission cy-
cle in neurons. J. Cell Sci. 126, 2187–2197.
Cassidy-Stone, A., Chipuk, J.E., Ingerman, E., Song, C., Yoo, C., Kuwana, T.,
Kurth, M.J., Shaw, J.T., Hinshaw, J.E., Green, D.R., and Nunnari, J. (2008).
Chemical inhibition of the mitochondrial division dynamin reveals its role in
Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev.
Cell 14, 193–204.
Chen, Y., and Dorn, G.W., 2nd. (2013). PINK1-phosphorylated mitofusin 2 is a
Parkin receptor for culling damaged mitochondria. Science 340, 471–475.
Cell Metabolism
PerspectiveChen, H., Detmer, S.A., Ewald, A.J., Griffin, E.E., Fraser, S.E., and Chan, D.C.
(2003). Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion
and are essential for embryonic development. J. Cell Biol. 160, 189–200.
Chen, H., Chomyn, A., and Chan, D.C. (2005). Disruption of fusion results in
mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280, 26185–
26192.
Chen, L., Gong, Q., Stice, J.P., and Knowlton, A.A. (2009). Mitochondrial
OPA1, apoptosis, and heart failure. Cardiovasc. Res. 84, 91–99.
Chen, H., Vermulst, M., Wang, Y.E., Chomyn, A., Prolla, T.A., McCaffery, J.M.,
and Chan, D.C. (2010a). Mitochondrial fusion is required for mtDNA stability in
skeletal muscle and tolerance of mtDNA mutations. Cell 141, 280–289.
Chen, Y., Lewis, W., Diwan, A., Cheng, E.H., Matkovich, S.J., and Dorn, G.W.,
2nd. (2010b). Dual autonomous mitochondrial cell death pathways are
activated by Nix/BNip3L and induce cardiomyopathy. Proc. Natl. Acad. Sci.
USA 107, 9035–9042.
Chen, Y., Liu, Y., and Dorn, G.W., 2nd. (2011). Mitochondrial fusion is essential
for organelle function and cardiac homeostasis. Circ. Res. 109, 1327–1331.
Chen, L., Liu, T., Tran, A., Lu, X., Tomilov, A.A., Davies, V., Cortopassi, G.,
Chiamvimonvat, N., Bers, D.M., Votruba, M., and Knowlton, A.A. (2012a).
OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction
and mtDNA instability. J. Am. Heart Assoc. 1, e003012.
Chen, Y., Csorda´s, G., Jowdy, C., Schneider, T.G., Csorda´s, N., Wang,W., Liu,
Y., Kohlhaas, M., Meiser, M., Bergem, S., et al. (2012b). Mitofusin 2-containing
mitochondrial-reticular microdomains direct rapid cardiomyocyte bioener-
getic responses via interorganelle Ca(2+) crosstalk. Circ. Res. 111, 863–875.
Chen, Y., Sparks, M., Bhandari, P., Matkovich, S.J., and Dorn, G.W., 2nd.
(2014). Mitochondrial genome linearization is a causative factor for cardiomy-
opathy in mice and Drosophila. Antioxid. Redox Signal. 21, 1949–1959.
Cipolat, S., Rudka, T., Hartmann, D., Costa, V., Serneels, L., Craessaerts, K.,
Metzger, K., Frezza, C., Annaert, W., D’Adamio, L., et al. (2006). Mitochondrial
rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-
dependent cristae remodeling. Cell 126, 163–175.
Clark, I.E., Dodson, M.W., Jiang, C., Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J.,
Hay, B.A., and Guo, M. (2006). Drosophila pink1 is required for mitochondrial
function and interacts genetically with parkin. Nature 441, 1162–1166.
Cogliati, S., Frezza, C., Soriano, M.E., Varanita, T., Quintana-Cabrera, R.,
Corrado, M., Cipolat, S., Costa, V., Casarin, A., Gomes, L.C., et al. (2013).
Mitochondrial cristae shape determines respiratory chain supercomplexes
assembly and respiratory efficiency. Cell 155, 160–171.
Davies, V.J., Hollins, A.J., Piechota, M.J., Yip, W., Davies, J.R., White, K.E.,
Nicols, P.P., Boulton, M.E., and Votruba, M. (2007). Opa1 deficiency in a
mouse model of autosomal dominant optic atrophy impairs mitochondrial
morphology, optic nerve structure and visual function. Hum. Mol. Genet. 16,
1307–1318.
de Brito, O.M., and Scorrano, L. (2008). Mitofusin 2 tethers endoplasmic retic-
ulum to mitochondria. Nature 456, 605–610.
Deas, E., Plun-Favreau, H., Gandhi, S., Desmond, H., Kjaer, S., Loh, S.H.,
Renton, A.E., Harvey, R.J., Whitworth, A.J., Martins, L.M., et al. (2011).
PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum.
Mol. Genet. 20, 867–879.
Delettre, C., Lenaers, G., Griffoin, J.M., Gigarel, N., Lorenzo, C., Belenguer, P.,
Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000). Nuclear
gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated
in dominant optic atrophy. Nat. Genet. 26, 207–210.
Ding,W.X., Ni, H.M., Li, M., Liao, Y., Chen, X., Stolz, D.B., Dorn, G.W., 2nd, and
Yin, X.M. (2010). Nix is critical to two distinct phases of mitophagy, reactive
oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-
mediated mitochondrial priming. J. Biol. Chem. 285, 27879–27890.
Disatnik, M.H., Ferreira, J.C., Campos, J.C., Gomes, K.S., Dourado, P.M., Qi,
X., and Mochly-Rosen, D. (2013). Acute inhibition of excessive mitochondrial
fission after myocardial infarction prevents long-term cardiac dysfunction.
J. Am. Heart Assoc. 2, e000461.
Diwan, A., Krenz, M., Syed, F.M., Wansapura, J., Ren, X., Koesters, A.G., Li,
H., Kirshenbaum, L.A., Hahn, H.S., Robbins, J., et al. (2007). Inhibition ofischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 re-
strains postinfarction remodeling in mice. J. Clin. Invest. 117, 2825–2833.
Diwan, A., Wansapura, J., Syed, F.M., Matkovich, S.J., Lorenz, J.N., and Dorn,
G.W., 2nd. (2008). Nix-mediated apoptosis links myocardial fibrosis, cardiac
remodeling, and hypertrophy decompensation. Circulation 117, 396–404.
Diwan, A., Matkovich, S.J., Yuan, Q., Zhao, W., Yatani, A., Brown, J.H.,
Molkentin, J.D., Kranias, E.G., and Dorn, G.W., 2nd. (2009). Endoplasmic retic-
ulum-mitochondria crosstalk in NIX-mediatedmurine cell death. J. Clin. Invest.
119, 203–212.
Doenst, T., Nguyen, T.D., and Abel, E.D. (2013). Cardiac metabolism in heart
failure: implications beyond ATP production. Circ. Res. 113, 709–724.
Dorn, G.W., 2nd. (2010). Mitochondrial pruning by Nix and BNip3: an essential
function for cardiac-expressed death factors. J. Cardiovasc. Transl. Res. 3,
374–383.
Dorn, G.W., 2nd. (2015). Gone fission.: diverse consequences of cardiac
drp1 deficiency. Circ. Res. 116, 225–228.
Dorn, G.W., 2nd, and Molkentin, J.D. (2004). Manipulating cardiac contractility
in heart failure: data from mice and men. Circulation 109, 150–158.
Dorn, G.W., 2nd, and Kitsis, R.N. (2015). Themitochondrial dynamism-mitoph-
agy-cell death interactome: multiple roles performed by members of a mito-
chondrial molecular ensemble. Circ. Res. 116, 167–182.
Dorn, G.W., 2nd, Clark, C.F., Eschenbacher, W.H., Kang, M.Y., Engelhard,
J.T., Warner, S.J., Matkovich, S.J., and Jowdy, C.C. (2011). MARF and
Opa1 control mitochondrial and cardiac function in Drosophila. Circ. Res.
108, 12–17.
Dorn, G.W., 2nd, Song, M., and Walsh, K. (2015). Functional implications of
mitofusin 2-mediated mitochondrial-SR tethering. J. Mol. Cell. Cardio. 78,
123–128.
DuBoff, B., Feany, M., and Go¨tz, J. (2013). Why size matters—balancing mito-
chondrial dynamics in Alzheimer’s disease. Trends Neurosci. 36, 325–335.
Ebert, A.D., Kodo, K., Liang, P., Wu, H., Huber, B.C., Riegler, J., Churko, J.,
Lee, J., de Almeida, P., Lan, F., et al. (2014). Characterization of the molecular
mechanisms underlying increased ischemic damage in the aldehyde dehydro-
genase 2 genetic polymorphism using a human induced pluripotent stem cell
model system. Sci. Transl. Med. 6, 255ra130.
Estaquier, J., and Arnoult, D. (2007). Inhibiting Drp1-mediated mitochondrial
fission selectively prevents the release of cytochrome c during apoptosis.
Cell Death Differ. 14, 1086–1094.
Fang, L., Moore, X.L., Gao, X.M., Dart, A.M., Lim, Y.L., and Du, X.J. (2007).
Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro
and in vivo. Life Sci. 80, 2154–2160.
Frank, S., Gaume, B., Bergmann-Leitner, E.S., Leitner, W.W., Robert, E.G.,
Catez, F., Smith, C.L., and Youle, R.J. (2001). The role of dynamin-related pro-
tein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515–525.
Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G.V.,
Rudka, T., Bartoli, D., Polishuck, R.S., Danial, N.N., De Strooper, B., and Scor-
rano, L. (2006). OPA1 controls apoptotic cristae remodeling independently
from mitochondrial fusion. Cell 126, 177–189.
Friedman, J.R., Lackner, L.L., West, M., DiBenedetto, J.R., Nunnari, J., and
Voeltz, G.K. (2011). ER tubules mark sites of mitochondrial division. Science
334, 358–362.
Givvimani, S., Munjal, C., Tyagi, N., Sen, U., Metreveli, N., and Tyagi, S.C.
(2012). Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure
overload induced heart failure. PLoS ONE 7, e32388.
Givvimani, S., Pushpakumar, S., Veeranki, S., and Tyagi, S.C. (2014). Dysregu-
lation of Mfn2 and Drp-1 proteins in heart failure. Can. J. Physiol. Pharmacol.
92, 583–591.
Glick, D., Zhang, W., Beaton, M., Marsboom, G., Gruber, M., Simon, M.C.,
Hart, J., Dorn, G.W., 2nd, Brady, M.J., and Macleod, K.F. (2012). BNip3 regu-
lates mitochondrial function and lipid metabolism in the liver. Mol. Cell. Biol.
32, 2570–2584.Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 203
Cell Metabolism
PerspectiveGuo, X., Disatnik, M.H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., and
Qi, X. (2013). Inhibition of mitochondrial fragmentation diminishes Hunting-
ton’s disease-associated neurodegeneration. J. Clin. Invest. 123, 5371–5388.
Hanna, R.A., Quinsay, M.N., Orogo, A.M., Giang, K., Rikka, S., and Gustafs-
son, A.B. (2012). Microtubule-associated protein 1 light chain 3 (LC3) interacts
with Bnip3 protein to selectively remove endoplasmic reticulum andmitochon-
dria via autophagy. J. Biol. Chem. 287, 19094–19104.
Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T.,
Ikeda, K., Ogata, T., and Matoba, S. (2013). Cytosolic p53 inhibits Parkin-
mediated mitophagy and promotes mitochondrial dysfunction in the mouse
heart. Nat. Commun. 4, 2308.
Ikeda, Y., Shirakabe, A., Maejima, Y., Zhai, P., Sciarretta, S., Toli, J., Nomura,
M., Mihara, K., Egashira, K., Ohishi, M., et al. (2015). Endogenous drp1 medi-
ates mitochondrial autophagy and protects the heart against energy stress.
Circ. Res. 116, 264–278.
Ingerman, E., Perkins, E.M., Marino, M., Mears, J.A., McCaffery, J.M., Hin-
shaw, J.E., and Nunnari, J. (2005). Dnm1 forms spirals that are structurally
tailored to fit mitochondria. J. Cell Biol. 170, 1021–1027.
Ishihara, N., Eura, Y., and Mihara, K. (2004). Mitofusin 1 and 2 play distinct
roles in mitochondrial fusion reactions via GTPase activity. J. Cell Sci. 117,
6535–6546.
Ishihara, N., Nomura, M., Jofuku, A., Kato, H., Suzuki, S.O., Masuda, K., Otera,
H., Nakanishi, Y., Nonaka, I., Goto, Y., et al. (2009). Mitochondrial fission factor
Drp1 is essential for embryonic development and synapse formation in mice.
Nat. Cell Biol. 11, 958–966.
Jin, S.M., Lazarou, M., Wang, C., Kane, L.A., Narendra, D.P., and Youle, R.J.
(2010). Mitochondrial membrane potential regulates PINK1 import and proteo-
lytic destabilization by PARL. J. Cell Biol. 191, 933–942.
Kageyama, Y., Hoshijima, M., Seo, K., Bedja, D., Sysa-Shah, P., Andrabi, S.A.,
Chen,W., Ho¨ke, A., Dawson, V.L., Dawson, T.M., et al. (2014). Parkin-indepen-
dent mitophagy requires Drp1 and maintains the integrity of mammalian heart
and brain. EMBO J. 33, 2798–2813.
Kasahara, A., Cipolat, S., Chen, Y., Dorn, G.W., 2nd, and Scorrano, L. (2013).
Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and
Notch signaling. Science 342, 734–737.
Kolwicz, S.C., Jr., Purohit, S., and Tian, R. (2013). Cardiac metabolism and its
interactions with contraction, growth, and survival of cardiomyocytes. Circ.
Res. 113, 603–616.
Koshiba, T., Detmer, S.A., Kaiser, J.T., Chen, H., McCaffery, J.M., and Chan,
D.C. (2004). Structural basis of mitochondrial tethering by mitofusin com-
plexes. Science 305, 858–862.
Kubli, D.A., Quinsay, M.N., and Gustafsson, A.B. (2013a). Parkin deficiency re-
sults in accumulation of abnormal mitochondria in aging myocytes. Commun.
Integr. Biol. 6, e24511.
Kubli, D.A., Zhang, X., Lee, Y., Hanna, R.A., Quinsay, M.N., Nguyen, C.K.,
Jimenez, R., Petrosyan, S., Murphy, A.N., and Gustafsson, A.B. (2013b).
Parkin protein deficiency exacerbates cardiac injury and reduces survival
following myocardial infarction. J. Biol. Chem. 288, 915–926.
Lee, S., Sterky, F.H., Mourier, A., Terzioglu, M., Cullheim, S., Olson, L., and
Larsson, N.G. (2012). Mitofusin 2 is necessary for striatal axonal projections
of midbrain dopamine neurons. Hum. Mol. Genet. 21, 4827–4835.
Li, J., Li, Y., Jiao, J., Wang, J., Li, Y., Qin, D., and Li, P. (2014). Mitofusin 1 is
negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol.
Cell. Biol. 34, 1788–1799.
Lian, X., Zhang, J., Azarin, S.M., Zhu, K., Hazeltine, L.B., Bao, X., Hsiao, C.,
Kamp, T.J., and Palecek, S.P. (2013). Directed cardiomyocyte differentiation
from human pluripotent stem cells by modulating Wnt/b-catenin signaling
under fully defined conditions. Nat. Protoc. 8, 162–175.
Liesa,M., and Shirihai, O.S. (2013). Mitochondrial dynamics in the regulation of
nutrient utilization and energy expenditure. Cell Metab. 17, 491–506.
Liu, X., Weaver, D., Shirihai, O., and Hajno´czky, G. (2009). Mitochondrial
‘kiss-and-run’: interplay between mitochondrial motility and fusion-fission
dynamics. EMBO J. 28, 3074–3089.204 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.Martin, O.J., Lai, L., Soundarapandian, M.M., Leone, T.C., Zorzano, A., Keller,
M.P., Attie, A.D., Muoio, D.M., and Kelly, D.P. (2014). A role for peroxisome
proliferator-activated receptor g coactivator-1 in the control of mitochondrial
dynamics during postnatal cardiac growth. Circ. Res. 114, 626–636.
Nakada, K., Inoue, K., Ono, T., Isobe, K., Ogura, A., Goto, Y.I., Nonaka, I., and
Hayashi, J.I. (2001). Inter-mitochondrial complementation: Mitochondria-
specific system preventing mice from expression of disease phenotypes by
mutant mtDNA. Nat. Med. 7, 934–940.
Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J.,
Cookson, M.R., and Youle, R.J. (2010). PINK1 is selectively stabilized on
impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298.
Olichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer, P., and
Lenaers, G. (2003). Loss of OPA1 perturbates the mitochondrial inner mem-
brane structure and integrity, leading to cytochrome c release and apoptosis.
J. Biol. Chem. 278, 7743–7746.
Ong, S.B., Subrayan, S., Lim, S.Y., Yellon, D.M., Davidson, S.M., and Hausen-
loy, D.J. (2010). Inhibiting mitochondrial fission protects the heart against
ischemia/reperfusion injury. Circulation 121, 2012–2022.
Otera, H., Wang, C., Cleland, M.M., Setoguchi, K., Yokota, S., Youle, R.J., and
Mihara, K. (2010). Mff is an essential factor for mitochondrial recruitment of
Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191,
1141–1158.
Palmer, C.S., Osellame, L.D., Laine, D., Koutsopoulos, O.S., Frazier, A.E., and
Ryan, M.T. (2011). MiD49 and MiD51, new components of the mitochondrial
fission machinery. EMBO Rep. 12, 565–573.
Papanicolaou, K.N., Khairallah, R.J., Ngoh, G.A., Chikando, A., Luptak, I.,
O’Shea, K.M., Riley, D.D., Lugus, J.J., Colucci, W.S., Lederer, W.J., et al.
(2011). Mitofusin-2 maintains mitochondrial structure and contributes to
stress-induced permeability transition in cardiac myocytes. Mol. Cell. Biol.
31, 1309–1328.
Papanicolaou, K.N., Kikuchi, R., Ngoh, G.A., Coughlan, K.A., Dominguez, I.,
Stanley, W.C., and Walsh, K. (2012a). Mitofusins 1 and 2 are essential for
postnatal metabolic remodeling in heart. Circ. Res. 111, 1012–1026.
Papanicolaou, K.N., Ngoh, G.A., Dabkowski, E.R., O’Connell, K.A., Ribeiro,
R.F., Jr., Stanley, W.C., and Walsh, K. (2012b). Cardiomyocyte deletion of
mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to
ROS-induced mitochondrial dysfunction and cell death. Am. J. Physiol. Heart
Circ. Physiol. 302, H167–H179.
Park, J., Lee, S.B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong,
M., Kim, J.M., and Chung, J. (2006). Mitochondrial dysfunction in Drosophila
PINK1 mutants is complemented by parkin. Nature 441, 1157–1161.
Parone, P.A., James, D.I., Da Cruz, S., Mattenberger, Y., Donze´, O., Barja, F.,
and Martinou, J.C. (2006). Inhibiting the mitochondrial fission machinery does
not prevent Bax/Bak-dependent apoptosis. Mol. Cell. Biol. 26, 7397–7408.
Pham, A.H., Meng, S., Chu, Q.N., and Chan, D.C. (2012). Loss of Mfn2 results
in progressive, retrograde degeneration of dopaminergic neurons in the
nigrostriatal circuit. Hum. Mol. Genet. 21, 4817–4826.
Piquereau, J., Caffin, F., Novotova, M., Prola, A., Garnier, A., Mateo, P., Fortin,
D., Huynh, H., Nicolas, V., Alavi, M.V., et al. (2012). Down-regulation of OPA1
alters mousemitochondrial morphology, PTP function, and cardiac adaptation
to pressure overload. Cardiovasc. Res. 94, 408–417.
Priori, S.G., Napolitano, C., Di Pasquale, E., and Condorelli, G. (2013). Induced
pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhyth-
mias. J. Clin. Invest. 123, 84–91.
Qi, X., Qvit, N., Su, Y.C., and Mochly-Rosen, D. (2013). A novel Drp1 inhibitor
diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 126,
789–802.
Santel, A., and Fuller, M.T. (2001). Control of mitochondrial morphology by a
human mitofusin. J. Cell Sci. 114, 867–874.
Sarraf, S.A., Raman, M., Guarani-Pereira, V., Sowa, M.E., Huttlin, E.L., Gygi,
S.P., and Harper, J.W. (2013). Landscape of the PARKIN-dependent ubiquity-
lome in response to mitochondrial depolarization. Nature 496, 372–376.
Schmidt, O., Pfanner, N., and Meisinger, C. (2010). Mitochondrial protein
import: from proteomics to functional mechanisms. Nat. Rev. Mol. Cell Biol.
11, 655–667.
Cell Metabolism
PerspectiveSchwarten, M., Mohrlu¨der, J., Ma, P., Stoldt, M., Thielmann, Y., Stangler, T.,
Hersch, N., Hoffmann, B., Merkel, R., andWillbold, D. (2009). Nix directly binds
to GABARAP: a possible crosstalk between apoptosis and autophagy. Auto-
phagy 5, 690–698.
Sebastia´n, D., Herna´ndez-Alvarez, M.I., Segale´s, J., Sorianello, E., Mun˜oz,
J.P., Sala, D., Waget, A., Liesa, M., Paz, J.C., Gopalacharyulu, P., et al.
(2012). Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum func-
tion with insulin signaling and is essential for normal glucose homeostasis.
Proc. Natl. Acad. Sci. USA 109, 5523–5528.
Sharma, A., Marceau, C., Hamaguchi, R., Burridge, P.W., Rajarajan, K.,
Churko, J.M., Wu, H., Sallam, K.I., Matsa, E., Sturzu, A.C., et al. (2014). Human
induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for
coxsackievirus B3-induced myocarditis and antiviral drug screening platform.
Circ. Res. 115, 556–566.
Shen, T., Zheng, M., Cao, C., Chen, C., Tang, J., Zhang, W., Cheng, H., Chen,
K.H., and Xiao, R.P. (2007). Mitofusin-2 is a major determinant of oxidative
stress-mediated heart muscle cell apoptosis. J. Biol. Chem. 282, 23354–
23361.
Shoffner, J.M., Watts, R.L., Juncos, J.L., Torroni, A., and Wallace, D.C. (1991).
Mitochondrial oxidative phosphorylation defects in Parkinson’s disease. Ann.
Neurol. 30, 332–339.
Siddall, H.K., Yellon, D.M., Ong, S.B., Mukherjee, U.A., Burke, N., Hall, A.R.,
Angelova, P.R., Ludtmann, M.H., Deas, E., Davidson, S.M., et al. (2013).
Loss of PINK1 increases the heart’s vulnerability to ischemia-reperfusion
injury. PLoS ONE 8, e62400.
Smirnova, E., Griparic, L., Shurland, D.L., and van der Bliek, A.M. (2001).
Dynamin-related protein Drp1 is required for mitochondrial division in mam-
malian cells. Mol. Biol. Cell 12, 2245–2256.
Song, Z., Ghochani, M., McCaffery, J.M., Frey, T.G., and Chan, D.C. (2009).
Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane
fusion. Mol. Biol. Cell 20, 3525–3532.
Song, M., Chen, Y., Gong, G., Murphy, E., Rabinovitch, P.S., and Dorn, G.W.,
2nd. (2014). Super-suppression of mitochondrial reactive oxygen species
signaling impairs compensatory autophagy in primary mitophagic cardiomy-
opathy. Circ. Res. 115, 348–353.
Song, M., Mihara, K., Chen, Y., Scorrano, L., and Dorn, G.W., 2nd. (2015).
Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic
culling in mouse hearts and cultured fibroblasts. Cell Metab. http://dx.doi.
org/10.1016/j.cmet.2014.12.011.
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O.J., Navar-
rete, E.G., Hu, S., Wang, L., Lee, A., et al. (2012). Patient-specific induced
pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci.
Transl. Med. 4, 130ra147.
Syed, F., Odley, A., Hahn, H.S., Brunskill, E.W., Lynch, R.A., Marreez, Y.,
Sanbe, A., Robbins, J., and Dorn, G.W., 2nd. (2004). Physiological growth syn-
ergizes with pathological genes in experimental cardiomyopathy. Circ. Res.
95, 1200–1206.Szabadkai, G., Simoni, A.M., Chami, M., Wieckowski, M.R., Youle, R.J., and
Rizzuto, R. (2004). Drp-1-dependent division of the mitochondrial network
blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated
apoptosis. Mol. Cell 16, 59–68.
Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., and Mihara, K. (2007). Mitotic
phosphorylation of dynamin-related GTPase Drp1 participates in mitochon-
drial fission. J. Biol. Chem. 282, 11521–11529.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K.,
and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human
fibroblasts by defined factors. Cell 131, 861–872.
Tieu, Q., and Nunnari, J. (2000). Mdv1p is a WD repeat protein that interacts
with the dynamin-related GTPase, Dnm1p, to trigger mitochondrial division.
J. Cell Biol. 151, 353–366.
Twig, G., Elorza, A., Molina, A.J., Mohamed, H., Wikstrom, J.D., Walzer, G.,
Stiles, L., Haigh, S.E., Katz, S., Las, G., et al. (2008). Fission and selective
fusion govern mitochondrial segregation and elimination by autophagy.
EMBO J. 27, 433–446.
Udagawa, O., Ishihara, T., Maeda, M., Matsunaga, Y., Tsukamoto, S.,
Kawano, N., Miyado, K., Shitara, H., Yokota, S., Nomura, M., et al. (2014).
Mitochondrial fission factor Drp1 maintains oocyte quality via dynamic rear-
rangement of multiple organelles. Curr. Biol. 24, 2451–2458.
Verhoeven, K., Claeys, K.G., Zu¨chner, S., Schro¨der, J.M., Weis, J., Ceuterick,
C., Jordanova, A., Nelis, E., De Vriendt, E., Van Hul, M., et al. (2006). MFN2mu-
tation distribution and genotype/phenotype correlation in Charcot-Marie-
Tooth type 2. Brain 129, 2093–2102.
Wakabayashi, J., Zhang, Z., Wakabayashi, N., Tamura, Y., Fukaya, M., Kens-
ler, T.W., Iijima, M., and Sesaki, H. (2009). The dynamin-related GTPase Drp1
is required for embryonic and brain development in mice. J. Cell Biol. 186,
805–816.
Yang, J.Y., and Yang, W.Y. (2013). Bit-by-bit autophagic removal of parkin-
labelled mitochondria. Nat. Commun. 4, 2428.
Youle, R.J., and van der Bliek, A.M. (2012). Mitochondrial fission, fusion, and
stress. Science 337, 1062–1065.
Yussman, M.G., Toyokawa, T., Odley, A., Lynch, R.A., Wu, G., Colbert, M.C.,
Aronow, B.J., Lorenz, J.N., and Dorn, G.W., 2nd. (2002). Mitochondrial death
protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomy-
opathy. Nat. Med. 8, 725–730.
Zesiewicz, T.A., Strom, J.A., Borenstein, A.R., Hauser, R.A., Cimino, C.R.,
Fontanet, H.L., Cintron, G.B., Staffetti, J.F., Dunne, P.B., and Sullivan, K.L.
(2004). Heart failure in Parkinson’s disease: analysis of the United Statesmedi-
care current beneficiary survey. Parkinsonism Relat. Disord. 10, 417–420.
Zhao, J., Liu, T., Jin, S., Wang, X., Qu, M., Uhle´n, P., Tomilin, N., Shupliakov,
O., Lendahl, U., and Niste´r, M. (2011). Human MIEF1 recruits Drp1 to mito-
chondrial outer membranes and promotes mitochondrial fusion rather than
fission. EMBO J. 30, 2762–2778.Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 205
